Here, the authors reveal that Kv11.1 activation induces lung cancer cell senescence and degrades c-Myc, suggesting Kv11.1 agonists as a promising therapeutic strategy for lung adenocarcinomas, potentially improving patient survival.
- Najmeh Eskandari
- Davide Delisi
- Saverio Gentile
